SecurityHEB / Hemispherx BioPharma, Inc. (42366C103)
Exec. Vice Chairman/CEO/Pres.Equels Thomas K.
IndustryBiological Products, Except Diagnostic Substances (Biotech)
Institutional Owners24
Institutional Shares3,642,408 - 7.71%
Common Shares Outstanding47,246,809 shares (as of 2018-06-30)
Institutional Value$ 1,346,000 USD

Institutional Stock Ownership and Shareholders

HEB / Hemispherx BioPharma, Inc. Institutional Ownership

Hemispherx BioPharma, Inc. (AMEX:HEB) has 24 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,642,408 shares. Largest shareholders include Sabby Management, LLC, BlackRock Institutional Trust Company, N.A., Vanguard Group Inc, BlackRock Inc., Geode Capital Management, Llc, Citadel Advisors Llc, Creative Planning, Northern Trust Corp, Virtu Financial LLC, and UBS Group AG.
Hemispherx BioPharma, Inc. (AMEX:HEB) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-07-30 13F-HR/A Virtu Financial LLC 34,330 30,718 -10.52 14 10 -28.57
2018-08-14 13F-HR GUGGENHEIM CAPITAL LLC 19,614 0 -100.00 8 0 -100.00
2018-10-10 13F-HR McAdam, LLC 342 0 -100.00 0 0
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 479,699 479,701 0.00 604 331 -45.20
2018-10-03 13F-HR/A Sound Income Strategies, Llc 9 9 0.00 0 0
2018-08-09 13F-HR BlackRock Inc. 457,380 458,448 0.23 181 146 -19.34
2017-02-10 13F-HR BlackRock Fund Advisors 5,284 6,904 30.66 7 5 -28.57
2018-08-13 13F-HR Advisor Group, Inc. 250 250 0.00 0 0
2018-09-18 13F-HR/A NORTHERN TRUST CORP 31,933 31,933 0.00 13 11 -15.38
2018-08-14 13F-HR Invesco Ltd. 13,626 4
2018-08-14 13F-HR TWO SIGMA SECURITIES, LLC 28,853 0 -100.00 11 0 -100.00
2018-08-09 13F-HR Waldron, LP 11,000 11,000 0.00 4 3 -25.00
2018-07-19 13F-HR HUNTINGTON NATIONAL BANK 2,501 0
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 1,080 1,080 0.00 0 0
2018-08-03 13F-HR Well Done, LLC 190 0 -100.00 0 0
2017-02-10 13F-HR BlackRock Advisors LLC 5,727 5,727 0.00 7 4 -42.86
2018-08-14 13F-HR UBS Group AG 1,714 20,658 1,105.25 1 7 600.00
2018-08-14 13F-HR BARCLAYS PLC 3 0 -100.00 0 0
2018-08-14 13F-HR MORGAN STANLEY 1,084 1,084 0.00 0 0
2018-10-12 13F-HR BANK OF MONTREAL /CAN/ 209 209 0.00 0 0
2018-07-20 13F-HR Creative Planning 40,001 40,001 0.00 16 13 -18.75
2018-08-14 13F-HR ROYAL BANK OF CANADA 21 2,000 9,423.81 0 1
2018-08-14 13F-HR Sabby Management, LLC 0 1,938,374 0 620
2018-08-14 13F-HR VANGUARD GROUP INC 451,169 467,574 3.64 178 150 -15.73
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 200,749 55,020 -72.59 79 18 -77.22
2018-10-15 13F-HR CITY HOLDING CO 417 417 0.00 0 0
2018-08-14 13F-HR DEUTSCHE BANK AG\ 24 24 0.00 0 0
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 74,832 74,832 0.00 29 23 -20.69
2018-08-14 13F-HR Jacobi Capital Management LLC 318 318 0.00 0 0

Related News Stories

Rounds Report: Eleven Train Is Moving Fast While Microcap Hemipherx Experienced Significant Insider Purchases

2018-05-02 seekingalpha
Eleven Biotherapeutics is continuing its highly robust trading momentum. There is a good chance that the upcoming clinical outcome for Vicinium monotherapy is positive. (77-3)

CUSIP: 42366C103